Does New York Medicaid Cover Wegovy? NY Medicaid Guide 2026
New York residents covered by Medicaid asking about Wegovy coverage, it depends on several factors. NY Medicaid — managed by the New York Medicaid agency — has specific formulary rules for Wegovy (semaglutide 2.4mg) that may surprise those coming from private plans.
NY Medicaid’s Preferred Drug List Position for Wegovy
Under federal law, Medicaid programs cannot exclude any drug from a manufacturer with a rebate agreement from manufacturers participating in the Medicaid Drug Rebate Program. Novo Nordisk participates in this program, meaning NY Medicaid has to provide coverage for Wegovy — though it may apply PA requirements and restrictions.
What this means:
- Wegovy is listed on NY Medicaid’s PDL with possible restrictions
- Prior authorization is mandatory for all enrollees
- Cost-sharing: $0–$3 for most Medicaid enrollees (federal rules cap Medicaid copays)
- Managed care organizations (MCOs) in New York could apply additional utilization management as permitted by NYDOH
Coverage for Different Diagnoses
For chronic weight management:
- Getting covered is the expected path when prescribed for chronic weight management
- Needed clinical support: prescriber attestation and clinical records
- Most New York MCOs will approve Wegovy after step therapy requirements are satisfied
For weight loss/obesity:
- NY Medicaid generally does not cover drugs prescribed solely for weight loss
- But, 2025 regulatory changes has created pathways for states to include anti-obesity medications as an optional benefit
- Check with NY Medicaid directly for the latest obesity drug coverage policy
Steps to Get Wegovy Approval Through NY Medicaid
- Coordinate with your prescriber file a prior authorization — Include complete clinical justification
- Know which managed care plan you’re on — New York Medicaid uses several MCOs, and each has slightly different PA criteria beyond the state’s preferred drug list
- File an exception request if denied — Federal law guarantee a process for coverage exceptions with clinical justification
- File a fair hearing — You can an administrative appeal after MCO denial of Wegovy
Key Points
- Cost isn’t the main issue: Compared to private plans, financial barriers are lower — the hurdle is prior authorization
- Dispensing: The majority of New York pharmacies are enrolled Medicaid providers, but specialty pharmacies specialty pharmacy dispensing of Wegovy
- 90-day supply: Some NY Medicaid MCOs allow mail-order dispensing to lower pharmacy visits